Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: Effect of α2- adrenoceptor blockade

Biological Psychiatry

Volumn 46, Issue 6, 1999, Pages 766-774

  Linnér, Love ^a   Arborelius, Lotta ^b   Nomikos, George G ^c   Bertilsson, Leif ^d   Svensson, Torgny H ^a  

^a Sect Neuropsychopharmacology   (Sweden)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

2 adrenoceptors; Electrophysiology; Microdialysis; Noradrenaline; Tricyclic antidepressants

Indexed keywords

IDAZOXAN; IMIPRAMINE; NORADRENALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXTRACELLULAR SPACE; FRONTAL LOBE; IDAZOXAN; IMIPRAMINE; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; TIME FACTORS;

EID: 0032846277     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00126-2     Document Type: Article

References (34)

1. Abercrombie E.D., Finlay J.M. Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC. Robinson T.E., Justice J.B. Microdialysis in the Neurosciences. 1991;253-274 Elsevier, Amsterdam.
2. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol. 352:1995;157-165.
3. 1A receptor antagonist (s)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn-Schmiedeberg's Arch Pharmacol. 353:1996;630-640.
4. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry. 51:1994;248-251.
5. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15:1992;243-245.
6. Blier P., de Montigny C. Electrophysiological investigations of the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci. 3:1983;1270-1278.
7. Brady L.S. Stress antidepressant drugs and the locus coeruleus. Brain Res Bull. 35:1994;545-556.
8. Brosen K., Klysner R., Gram L.F., Otton S.V., Bech P., Bertilsson L. Steady state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism. Eur J Clin Pharmacol. 30:1986;679-684.
9. Ceci A., Borsini F. Effects of desipramine and maprotiline on the coeruleus-cortical noradrenergic system in anaesthetized rats. Eur J Pharmacol. 312:1996;189-193.
10. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors Electrophysiological studies in the rat brain . Naunyn Schmiedeberg's Arch Pharmacol. 333:(4):1986;342-348.
11. Cremers TIFH, de Boer P, Westerink BHC, Wikström H (1998): Relevance of SSRI plasma concentrations in relation to apparent serotonergic autoreceptor activation and chronic treatment regimens. Soc Neurosci Abstr 24(1):439.15, p. 1112.
12. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry. 47:1990;411-418.
13. Delgado P.L., Miller H.L., Salomon R.M., Licino J., Heninger G.R., Gelenberg A.J., et al. Monoamines and the mechanism of antidepressant action Effects of catecholamine depletion on mood in patients treated with antidepressants . Psychopharmacol Bull. 29:1993;389-396.
14. Dennis T., L'Heureux R., Carter C., Scatton B. Presynaptic Alpha-2 adrenoceptors play a major role in the effects of IDA on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther. 241:1987;642-649.
15. 2 sites in the mammalian central nervous system. Pharmacol Ther. 68:1995;175-208.
16. 2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J Neurochem. 69:1997;2616-2619.
17. Graham A.W., Aghajanian G.K. Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature. 234:1971;100-102.
18. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo A microdialysis study . J Neurochem. 60:1993;776-779.
19. Invernizzi R., Bramante M., Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output Role of presynaptic 5-HT1A receptors . Eur J Pharmacol. 260:(2-3):1994;243-246.
20. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther. 274:(2):1995;866-876.
21. Lacroix D., Blier P., Curet O., de Montigny C. Effects of long term desipramine administration on noradrenergic neurotransmission Electrophysiological studies in the rat brain . J Pharmacol Exp Ther. 257:1991;1081-1090.
22. L'Heureux R., Dennis T., Curet O., Scatton B. Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis Effects of drugs affecting noradrenergic transmission . J Neurochem. 46:1986;1794-1801.
23. 2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J. Neurochem. 71:1998;790-798.
24. 1-imidazoline receptors in rat brain. Brain Res. 744:1997;216-226.
25. Nybäck H.V., Walters J.R., Aghajanian G.K., Roth R.H. Tricyclic antidepressants Effects on the firing rate of brain noradrenergic neurons . Eur J Pharmacol. 32:1975;302-312.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, Sydney, Australia.
27. Pineda J., Ugedo L., Garcia-Sevilla J.A. Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones Possible involvement of imidazoline-preferring receptors . Naunyn Schmiedeberg's Arch Pharmacol. 348:1993;134-140.
28. Reuter L.E., Kasamo K., de Montigny C., Blier P. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol. 357:1998;600-610.
29. Svensson T.H. Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine. Naunyn-Schmiedeberg's Arch Pharmacol. 302:1978;115-118.
30. Svensson T.H., Usdin T. Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants α-receptor mediation . Science. 202:1978;1089-1091.
31. Svensson T.H., Usdin T. Alpha-adrenoceptor mediated inhibition of brain noradrenergic neurons after acute and chronic treatment with tricyclic antidepressants. Usdin E., Kopin I.J., Barchas J. Catecholamines Basic and Clinical Frontiers . 1979;672-674 Pergamon Press, New York.
32. Svensson T.H., Linner L., Arborelius L. Electrophysiology of brain noradrenaline neurons and the mode of antidepressant drugs. Briley M., Montgomery S. Antidepressant Therapy at the Dawn of the 3rd Millennium. 1998;19-35 Martin Dunitz Ltd, London, England.
33. Tanda G., Frau T., Di Chiara G. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacol. 127:1996;83-87.
34. Valentino R.J., Curtis A.L., Parris D.G., Wehby R.G. Antidepressant action on brain noradrenergic neurons. J Pharmacol Exp Ther. 253:1990;833-840.